Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Mar
28
2025
 HHS Job Cuts: FDA, CDC, NIH and CMS Impacted Amidst Significant Restructurings Polsinelli PC
Mar
28
2025
 Nebraska Considers Sales Tax on Candy and Soft Drinks Keller and Heckman LLP
Mar
28
2025
 FDA Announces a “Chemical Contaminants Transparency Tool” to Evaluate Potential Health Risks of Contaminants in Human Foods. Keller and Heckman LLP
Mar
28
2025
 Illinois Moving Forward with BVO Ban Keller and Heckman LLP
Mar
27
2025
 Behavioral Health Law Ledger | March 2025 Greenberg Traurig, LLP
Mar
27
2025
 EPA Extends 2024 RFS Compliance Reporting Deadline Bergeson & Campbell, P.C.
Mar
27
2025
 CLP Changes And What They Mean For Commercial Operations — A Conversation with Karin Baron and Lioba Oerter [Podcast] Bergeson & Campbell, P.C.
Mar
27
2025
 China Releases New Rules Regarding the Use of Facial Recognition Technology Hunton Andrews Kurth
Mar
27
2025
 What’s the (Re)issue? Patent Term Extensions for Reissue Patents McDermott Will & Emery
Mar
27
2025
 China Releases Draft Implementation Measures for the Protection of Drug Trial Data Including Data Exclusivity for Foreign-Originated Drugs Schwegman, Lundberg & Woessner, P.A.
Mar
26
2025
 Ghost Guns and the Bankruptcy Code: Neither Provides Ammunition for Dismissing Actions - SCOTUS Today Epstein Becker & Green, P.C.
Mar
26
2025
 This Week in 340B: March 18 – 24, 2025 McDermott Will & Emery
Mar
25
2025
 DEA Buprenorphine Rule Delayed to December 31, 2025 Foley & Lardner LLP
Mar
25
2025
 Telehealth Cliff Averted, for Now (But September is Six Months Away) Epstein Becker & Green, P.C.
Mar
25
2025
 The End of the Self-Affirmed GRAS Pathway? Epstein Becker & Green, P.C.
Mar
24
2025
 Ex officio interventions by the Anti-Corruption and Good Government Ministry in public tenders in México OLIVARES
Mar
24
2025
 DEA Telemedicine Rules Further Delayed Until (Nearly) 2026 Epstein Becker & Green, P.C.
Mar
24
2025
 The Ketamine Administration Market: A Legal Guide for Healthcare Entities MDRX Law - Sauchik & Giyaur, P.C.
Mar
24
2025
 Federal Circuit Decision Could Encourage More Reissue Patents Foley & Lardner LLP
Mar
24
2025
 West Virginia Set to Ban Certain Food Additives and Colors Keller and Heckman LLP
Mar
24
2025
 What Vice Chancellor Strine Got Wrong In Massey Energy Co. Allen Matkins Leck Gamble Mallory & Natsis LLP
Mar
24
2025
 FDA Plans to Extend Compliance Date for Food Traceability Rule Keller and Heckman LLP
Mar
21
2025
 HHS-OIG Highlights Anti-Fraud Safeguards of Drug Manufacturer’s Free Drug Program for Patients in Financial Need Barnes & Thornburg LLP
Mar
21
2025
 Federal Circuit Confirms Calculation of PTE for Reissue Patents Under Regulatory Review Barnes & Thornburg LLP
Mar
21
2025
 McDermott+ Check-Up: March 21, 2025 McDermott Will & Emery
Mar
21
2025
 FDA’s Semaglutide Shortage Resolution: Legal Implications and Risks for Compounding Pharmacies Sheppard, Mullin, Richter & Hampton LLP
Mar
21
2025
 President Trump Revokes 2022 EO on Advancing Biotechnology and Biomanufacturing Bergeson & Campbell, P.C.
Mar
20
2025
 Maine Considers Bill to Establish Maximum Levels of PFAS in Farm Products Keller and Heckman LLP
Displaying 1 - 28 of 12085
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters